mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.13 |
0.03 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.03 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.03 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.03 |
mRNA |
QL-VIII-58 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.03 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.04 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.04 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.04 |